Inactive Instrument
Pandion Therapeutics, Inc. Stock
Stocks
PAND
US6983401067
Biotechnology & Medical Research
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 58 | - |
| Chief Tech/Sci/R&D Officer | - | 2020-07-31 | |
Edward Freedman
COO | Chief Operating Officer | 57 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/1/21 | Tender | Executive/Senior Manager | 189,780 | 0.6430% | ||
| 4/1/21 | Tender | Chief Technology Officer | 335,035 | 1.1351% | ||
| 4/1/21 | New Leaf Venture Partners LLC
| Tender | Company | 2,827,883 | 9.5810% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +0.13% | - | - | 1.7B | |
| -1.06% | +9.92% | +59.12% | +68.61% | 68.32B | |
| +1.30% | +10.98% | +17.47% | +92.69% | 60.26B | |
| +0.39% | +1.75% | +24.27% | +98.33% | 55.86B | |
| -0.95% | +18.30% | +27.58% | +110.93% | 48.43B | |
| -0.23% | +4.55% | +28.86% | +40.08% | 45.34B | |
| -6.40% | -6.97% | +188.06% | +816.79% | 41.76B | |
| +1.97% | +9.00% | +25.20% | +50.98% | 34.5B | |
| -0.56% | -4.25% | +89.87% | +65.40% | 33.8B | |
| -1.49% | +13.52% | +43.09% | +0.06% | 25.96B | |
| Average | -0.68% | +4.29% | +55.95% | +149.32% | 46B | |
| Weighted average by Cap. | -0.69% | +4.03% | +53.04% | +147.34% |
Employees
56
